Opportunity Information: Apply for RFA CA 20 051

The National Institutes of Health (NIH) funding opportunity RFA-CA-20-051, titled "Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required)," supports research projects that create, tailor, and rigorously test interventions aimed at reducing cancer risk in rural communities. The central focus is primary prevention, meaning applicants are expected to target upstream, changeable drivers of cancer risk before cancer develops, rather than concentrating on treatment. NIH is looking for intervention research that works at the individual level, the community level, or across multiple levels at once (for example, combining patient-focused behavior change support with clinic workflow changes and community-based resources). Because the mechanism is an R01 with a clinical trial requirement, proposed work is expected to include a prospective intervention study in people, with outcomes that can demonstrate whether the intervention actually works.

A major emphasis is on tackling social and behavioral risk factors that contribute to higher cancer burden and worse outcomes in rural populations. While the announcement does not list specific risk factors as requirements, it is clearly oriented toward modifiable behaviors and social conditions that influence cancer risk and cancer disparities, such as tobacco use, unhealthy diet, physical inactivity, alcohol use, HPV vaccination-related behaviors, screening uptake behaviors, and other prevention-relevant actions, as well as the real-world social and cultural context shaping those behaviors. The opportunity highlights that rural cancer disparities are not only about geography itself, but also about "non-geographic aspects of rurality" that can vary widely across rural places, including economic conditions, local norms, occupational exposures and patterns, resource limitations, and community infrastructure. NIH is signaling that strong applications will be thoughtful about what "rural" means in the specific target setting and will measure and address the factors that are driving risk in that setting, rather than assuming rural communities are all the same.

The announcement also strongly encourages applicants to confront social determinants of health and access barriers that can block prevention efforts in rural areas. This includes issues like limited healthcare availability, shortages of specialty care, transportation challenges, broadband and technology constraints, insurance and cost barriers, literacy and language needs, and cultural factors that influence trust and engagement. The intent is not just to deliver an intervention, but to design it in a way that fits rural realities and reduces barriers that routinely prevent rural residents from benefiting from cancer prevention strategies. Relatedly, NIH notes the value of more granular data and geospatial information, suggesting that applicants can use local, place-based data to customize interventions to the needs of particular communities, counties, or regions, rather than using a one-size-fits-all approach.

Another key theme is implementation science, meaning NIH is interested not only in whether an intervention can work under ideal conditions, but also how to integrate proven cancer control and prevention strategies into programs that are coordinated, sustainable, and scalable in rural contexts. Applications are encouraged to build interventions that can be embedded in real service systems and maintained over time, with room for local adaptation. The announcement explicitly frames sustainability as a priority: interventions should strengthen or enhance existing programs so that, if successful, they can continue beyond the study period and expand to improve population health downstream.

Collaboration expectations are also prominent. Applicants are strongly encouraged to partner with organizations that already have trusted relationships, service infrastructure, or delivery platforms in rural communities, especially those addressing other health or social needs that overlap with cancer prevention. Examples given include Federally Qualified Health Centers (FQHCs), community health centers, and rural health centers, as well as programs with capabilities like telemedicine and behavioral health services. The underlying idea is that rural cancer prevention can often move faster and last longer when it is integrated into institutions that rural residents already rely on, rather than being built entirely from scratch.

In terms of who can apply, eligibility is broad across U.S.-based public and private entities. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled colleges and universities; private institutions of higher education; federally recognized tribal governments; other tribal organizations; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status; and for-profit organizations (other than small businesses), as well as small businesses and other organizations. The opportunity also calls out additional eligible applicant types commonly included in NIH announcements, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, it clearly restricts foreign involvement: non-U.S. entities are not eligible to apply as applicants, non-U.S. components of U.S. organizations are not eligible, and foreign components (as NIH defines them in policy) are not allowed.

Administratively, this is an NIH discretionary grant under the R01 mechanism, aligned with education and health activity categories, with CFDA number 93.393. The source data lists an award ceiling of $700,000 (as provided in the opportunity record). The original closing date in the record is January 18, 2022, and the opportunity was created on September 15, 2020. Overall, the funding announcement is aimed at building a stronger evidence base for what actually reduces cancer risk in rural America, while paying close attention to the social, cultural, healthcare, and technology realities that shape prevention efforts and determine whether effective interventions can be delivered, adopted, and sustained at scale.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393.
  • This funding opportunity was created on 2020-09-15.
  • Applicants must submit their applications by 2022-01-18. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $700,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA CA 20 051

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)

Previous opportunity: Announcement for Program Funding for NRCS’ Conservation Innovation Grants (CIG) for Federal fiscal year (FY) 2020 – Idaho

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 20 051

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 20 051) also looked into and applied for these:

Funding Opportunity
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed) Apply for PAR 20 304

Funding Number: PAR 20 304
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed) Apply for RFA CA 20 043

Funding Number: RFA CA 20 043
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) Apply for RFA CA 20 046

Funding Number: RFA CA 20 046
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21 Clinical Trial Not Allowed) Apply for RFA MH 20 702

Funding Number: RFA MH 20 702
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01 Clinical Trial Not Allowed) Apply for RFA MH 20 701

Funding Number: RFA MH 20 701
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required) Apply for PAR 20 305

Funding Number: PAR 20 305
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,400,000
Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional) Apply for PAR 20 310

Funding Number: PAR 20 310
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) Apply for PAR 21 044

Funding Number: PAR 21 044
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) Apply for PAR 20 314

Funding Number: PAR 20 314
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) Apply for PAR 20 313

Funding Number: PAR 20 313
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Discovery of Cell-based Chemical Probes for Novel Brain Targets (R21 Clinical Trial Not Allowed) Apply for PAR 21 028

Funding Number: PAR 21 028
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) Apply for PAR 21 029

Funding Number: PAR 21 029
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical Trial Not Allowed) Apply for RFA CA 20 054

Funding Number: RFA CA 20 054
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $499,999
Elucidation of mechanisms underlying complex morbidities of SUD and other mental Illnesses in people living with HIV/AIDS (R01 Clinical Trial Optional) Apply for RFA DA 21 012

Funding Number: RFA DA 21 012
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Not Allowed) Apply for RFA CA 20 056

Funding Number: RFA CA 20 056
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Use and Addiction Scientists (R25 Clinical Trials Not Allowed) Apply for PAR 20 236

Funding Number: PAR 20 236
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) Apply for RFA CA 20 055

Funding Number: RFA CA 20 055
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required) Apply for RFA CA 20 057

Funding Number: RFA CA 20 057
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) Apply for PAR 21 035

Funding Number: PAR 21 035
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) Apply for PAR 21 033

Funding Number: PAR 21 033
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 20 051", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: